Which of the following lab tests is appropriate to evaluate potential underlying causes of focal seizures?

Prepare for the PANCE Neurology Test with comprehensive materials. Use flashcards and multiple-choice questions, each featuring hints and explanations. Boost your confidence and ace your exam!

Multiple Choice

Which of the following lab tests is appropriate to evaluate potential underlying causes of focal seizures?

Evaluating potential underlying causes of focal seizures starts with broad, rapid screening for reversible metabolic and systemic triggers. The combination of CBC, CMP, and a fingerstick glucose covers the most common and immediately addressable issues that can provoke seizures: infections or inflammatory processes (CBC can show leukocytosis or anemia), electrolyte and organ function status (CMP reveals sodium, potassium, calcium, bicarbonate, kidney and liver function), and glucose abnormalities (a fingerstick glucose quickly rules in or out hypo- or hyperglycemia). These tests are quick, widely available, and directly inform immediate management. Other lab sets don’t address this spectrum as effectively. A lipid panel and LFTs alone miss crucial acute metabolic disturbances and infection indicators; while LFTs are part of the CMP, a separate lipid panel isn’t helpful for acute seizure evaluation. Coagulation studies like prothrombin time and aPTT focus on bleeding risk and clotting disorders rather than reversible seizure triggers, so they don’t serve as broad initial screening for underlying causes. A CBC alone lacks information about electrolytes, glucose, and renal/hepatic function, making it less useful as a first-line evaluation for this purpose.

Evaluating potential underlying causes of focal seizures starts with broad, rapid screening for reversible metabolic and systemic triggers. The combination of CBC, CMP, and a fingerstick glucose covers the most common and immediately addressable issues that can provoke seizures: infections or inflammatory processes (CBC can show leukocytosis or anemia), electrolyte and organ function status (CMP reveals sodium, potassium, calcium, bicarbonate, kidney and liver function), and glucose abnormalities (a fingerstick glucose quickly rules in or out hypo- or hyperglycemia). These tests are quick, widely available, and directly inform immediate management.

Other lab sets don’t address this spectrum as effectively. A lipid panel and LFTs alone miss crucial acute metabolic disturbances and infection indicators; while LFTs are part of the CMP, a separate lipid panel isn’t helpful for acute seizure evaluation. Coagulation studies like prothrombin time and aPTT focus on bleeding risk and clotting disorders rather than reversible seizure triggers, so they don’t serve as broad initial screening for underlying causes. A CBC alone lacks information about electrolytes, glucose, and renal/hepatic function, making it less useful as a first-line evaluation for this purpose.

More practice questions